Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

216 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial.
Welsh JL, Wagner BA, van't Erve TJ, Zehr PS, Berg DJ, Halfdanarson TR, Yee NS, Bodeker KL, Du J, Roberts LJ 2nd, Drisko J, Levine M, Buettner GR, Cullen JJ. Welsh JL, et al. Among authors: halfdanarson tr. Cancer Chemother Pharmacol. 2013 Mar;71(3):765-75. doi: 10.1007/s00280-013-2070-8. Epub 2013 Feb 5. Cancer Chemother Pharmacol. 2013. PMID: 23381814 Free PMC article. Clinical Trial.
Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors.
Chauhan A, Chan K, Halfdanarson TR, Bellizzi AM, Rindi G, O'Toole D, Ge PS, Jain D, Dasari A, Anaya DA, Bergsland E, Mittra E, Wei AC, Hope TA, Kendi AT, Thomas SM, Flem S, Brierley J, Asare EA, Washington K, Shi C. Chauhan A, et al. Among authors: halfdanarson tr. CA Cancer J Clin. 2024 Apr 29. doi: 10.3322/caac.21840. Online ahead of print. CA Cancer J Clin. 2024. PMID: 38685134 Free article.
Presacral Neuroendocrine Neoplasms: A Multi-site Review of Surgical Outcomes.
Violante T, Murphy B, Ferrari D, Graham RP, Navin P, Merchea A, Larson DW, Dozois EJ, Halfdanarson TR, Perry WR. Violante T, et al. Among authors: halfdanarson tr. Ann Surg Oncol. 2024 Apr 28. doi: 10.1245/s10434-024-15328-3. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38679679
Transforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilot.
Tevaarwerk AJ, Karam D, Gatten CA, Harlos ES, Maurer MJ, Giridhar KV, Haddad TC, Alberts SR, Holton SJ, Stockham A, Leventakos K, Hubbard JM, Mansfield AS, Halfdanarson TR, Chen R, Jochum JA, Schwecke AS, Eiring RA, Carroll JL, Riaz IB, McWilliams RR, Galanis E, Mandrekar SJ. Tevaarwerk AJ, et al. Among authors: halfdanarson tr. Cancer. 2024 Apr 25. doi: 10.1002/cncr.35304. Online ahead of print. Cancer. 2024. PMID: 38662502
Theranostics and artificial intelligence: new frontiers in personalized medicine.
Belge Bilgin G, Bilgin C, Burkett BJ, Orme JJ, Childs DS, Thorpe MP, Halfdanarson TR, Johnson GB, Kendi AT, Sartor O. Belge Bilgin G, et al. Among authors: halfdanarson tr. Theranostics. 2024 Mar 25;14(6):2367-2378. doi: 10.7150/thno.94788. eCollection 2024. Theranostics. 2024. PMID: 38646652 Free PMC article. Review.
Comparison of Octreotide and Vasopressors as First-Line Treatment for Intraoperative Carcinoid Crisis.
Ammann M, Kinney MAO, Gudmundsdottir H, Santol J, Thiels CA, Warner SG, Truty MJ, Kendrick ML, Smoot RL, Anderson AL, Halfdanarson TR, Nagorney DM, Starlinger PP. Ammann M, et al. Among authors: halfdanarson tr. Ann Surg Oncol. 2024 Apr 15. doi: 10.1245/s10434-024-15264-2. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38619707 No abstract available.
216 results